EPISODE · Oct 21, 2022 · 33 MIN
Clinical Trials and Post-Market Side Effects
from Experts InSight
Drs. Sarah Read, M. Ali Khan, and Ajay Kuriyan join a group discussion on incorporating newly approved medications into practice, focusing on real-world examples of Vuity (pilocarpine drops), brolucizumab, and drugs for dry AMD in trial. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
NOW PLAYING
Clinical Trials and Post-Market Side Effects
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m